Canada · Delayed Price · Currency is CAD Defence Therapeutics Statistics
Total Valuation
CSE:DTC has a market cap or net worth of CAD 42.14 million. The enterprise value is 42.41 million.
| Market Cap | 42.14M |
| Enterprise Value | 42.41M |
Important Dates
The next estimated earnings date is Wednesday, November 12, 2025.
| Earnings Date | Nov 12, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
CSE:DTC has 54.73 million shares outstanding. The number of shares has increased by 11.64% in one year.
| Current Share Class | 54.73M |
| Shares Outstanding | 54.73M |
| Shares Change (YoY) | +11.64% |
| Shares Change (QoQ) | +11.16% |
| Owned by Insiders (%) | 4.15% |
| Owned by Institutions (%) | n/a |
| Float | 52.45M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | -33.55 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -12.04 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | -12.49 |
Financial Position
The company has a current ratio of 0.50
| Current Ratio | 0.50 |
| Quick Ratio | 0.49 |
| Debt / Equity | n/a |
| Debt / EBITDA | n/a |
| Debt / FCF | -0.44 |
| Interest Coverage | -9.89 |
Financial Efficiency
| Return on Equity (ROE) | n/a |
| Return on Assets (ROA) | -187.25% |
| Return on Invested Capital (ROIC) | n/a |
| Return on Capital Employed (ROCE) | 253.99% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +28.33% in the last 52 weeks. The beta is 1.32, so CSE:DTC's price volatility has been higher than the market average.
| Beta (5Y) | 1.32 |
| 52-Week Price Change | +28.33% |
| 50-Day Moving Average | 0.76 |
| 200-Day Moving Average | 0.86 |
| Relative Strength Index (RSI) | 45.75 |
| Average Volume (20 Days) | 58,344 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -3.19M |
| Pretax Income | -3.52M |
| Net Income | -3.52M |
| EBITDA | -3.12M |
| EBIT | -3.19M |
| Earnings Per Share (EPS) | -0.07 |
Balance Sheet
The company has 1.23 million in cash and 1.50 million in debt, giving a net cash position of -271,836 or -0.00 per share.
| Cash & Cash Equivalents | 1.23M |
| Total Debt | 1.50M |
| Net Cash | -271,836 |
| Net Cash Per Share | -0.00 |
| Equity (Book Value) | -1.26M |
| Book Value Per Share | -0.02 |
| Working Capital | -1.44M |
Cash Flow
In the last 12 months, operating cash flow was -3.40 million and capital expenditures 3,597, giving a free cash flow of -3.40 million.
| Operating Cash Flow | -3.40M |
| Capital Expenditures | 3,597 |
| Free Cash Flow | -3.40M |
| FCF Per Share | -0.06 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
CSE:DTC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -11.64% |
| Shareholder Yield | -11.64% |
| Earnings Yield | -8.36% |
| FCF Yield | -8.06% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |